Lux Capital: $5 billion in assets under management

What we found

The funds

Lux Capital manages a portfolio of funds with varying sizes and stages. The firm’s total assets under management reached $5 billion as of 2021. Among its recent vehicles, the Lux Ventures VIII fund closed at a size of $1.15 billion. Looking further back, the Lux Ventures V fund had a size of $400M as of 2024, while the Lux Capital Venture Fund IV targeted a size of $350M in 2015. More recently, Lux Capital Fund IX reached a size of $1.5B as of 2026. The firm has also engaged in specific fundraising activities for different investment strategies. Lux Capital raised $1.5 billion to invest in and create new startups. Additionally, Lux Capital closed an $800 million growth-stage fund and a $675 million early-stage venture fund. These figures illustrate the scale of capital deployed across the firm’s various investment vehicles over time. [1] [5] [6] [12]

The firm

Lux Capital was founded in 2000 and focuses on investments in emerging technologies. The firm invests in emerging science and technology companies, supporting founders building businesses across physical, computational, and life sciences, including AI, biotechnology, robotics, and defense. Its investment strategy is built around a deep commitment to transformative science and technology, particularly where computational advancements intersect with the physical world. Lux seeks to invest in areas where computation can revolutionize traditional industries, such as AI-driven biotech and autonomous systems. A key aspect of its strategy is a contrarian approach, backing non-consensus founders and sectors often overlooked by mainstream venture capital. The firm emphasizes a long-term perspective, described as a “Five-Year Psychological Bias,” which prioritizes patience and strategic company-building over a decade-long horizon. This approach includes supporting companies through downturns and facilitating strategic M&A. Lux Capital also emphasizes sector specialization and technical expertise, particularly in AI, biotechnology, aerospace, and energy. This focus allows the firm to engage with companies at the forefront of technological convergence, such as the intersection of AI and biotechnology. Entrepreneurs receive not only financial support but also strategic guidance and operational assistance to help them scale. Lux Capital is renowned for its distinctive approach to venture capital, leveraging a powerful network and deep industry insights to propel its portfolio companies to success. In January 2026, the firm reported $7 billion in assets under management. It also manages Lux Ventures IX, a $1.5 billion investment fund. [7] [8] [9] [13]

The people

Josh Wolfe is a published scientist, a Cornell alum, and a Trustee of the Santa Fe Institute. He co-founded over 20 Lux companies from scratch. Additionally, he co-founded and chaired Coney Island Prep charter school. Lux Capital has strengthened its partnership over the past year with key appointments and promotions, reflecting growth and talent development. No high-profile executive departures have been publicly announced in this period. In May 2024, founder Girish Mathrubootham stepped down as CEO. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. [10] [14] [15]

What the firm says

Lux Capital describes its mission as advancing human health, enabling creativity and free expression, increasing productivity, progressing science, and securing life and the environment. The firm states that cultures get what they celebrate, arguing that Congress must support long-horizon science and defend American values from foreign interference. Lux Capital asserts that America must commit to advancing scientific progress by upgrading funding institutions to cultivate long-term horizons. It notes that many of its brightest contributors are immigrants from Vietnam, Pakistan, India, Israel, and China, and argues that the U.S. should attract top global talent. The firm contends that diverse voices are stronger than any authoritarian regime and that individual pioneers can outpace centralized plans. It emphasizes that none of its companies would exist without decades of foundational scientific work. Lux Capital views the American Dream as its greatest asset in the global competitive landscape and states there is no place for foreign interference in universities, scientific institutions, companies, economies, or political systems. It argues that America must give scientists the freedom to consider the hardest questions. To avoid failure, the firm says it needs long-term scientific funding and contributions from talented minds yearning for freedom. By doing these things, Lux Capital says it will illustrate the contrast between a world led by the U.S. and one ruled by the CCP. The firm maintains a broad frontier-technology mandate with a current research focus on embodied intelligence. Its strongest investment fit is in robotics, physical AI, and defense. A recent third-quarter report documented Physical Intelligence activity. Lux Capital’s investment focus areas include biology, biochemistry, chemistry, material science, engineering, electronics, infrastructure, computer science, physics, and aerospace. The firm’s fund size is $5 billion. [2] [11] [16]

Fund ledger

Each fund's figures as its sources state them. A target, a hard cap or an early close is not what the fund raised.

Where the sources disagree

• Portfolio outcomes. Asked, and the search found no public statement either way.
• What the press says. Asked, and the search found no public statement either way.

Analysis

The manager operates with a substantial scale, reporting $7 billion in assets under management as of January 2026, which supports its ability to sustain long-term commitments to portfolio companies. [13]

Lux Capital pursues a contrarian investment strategy that backs non-consensus founders and sectors often overlooked by mainstream venture capital, differentiating its portfolio from typical market trends. [9]

The firm employs a “Five-Year Psychological Bias,” emphasizing patience and strategic company-building over a decade-long horizon rather than seeking rapid exits. [9]

Investment focus is concentrated on the intersection of computational advancements and the physical world, with specific strengths in robotics, physical AI, and defense. [9] [11]

The manager’s mission explicitly includes securing life and the environment, alongside advancing human health and progressing science, indicating a broad mandate beyond pure financial returns. [16]

Lux Capital’s leadership includes Josh Wolfe, a published scientist and Cornell alum who has co-founded over 20 Lux companies, suggesting deep technical expertise within the management team. [10]

Pros and cons for an LP weighing a commitment to this manager

Pros

• The manager has demonstrated significant capital raising capability, growing its total assets under management from $5 billion in 2021 to a reported $7 billion in January 2026, indicating strong LP confidence and scale. [5] [13]
• Lux Capital successfully closed a $1.5 billion fund (Lux Ventures IX) in 2026, which is larger than the $1.15 billion final close of its previous Lux Ventures VIII fund, showing an ability to attract larger commitments over time. [1] [5] [6] [13]
• The firm maintains a stable and growing leadership team, with no high-profile executive departures publicly announced in the recent period, suggesting operational continuity and institutional strength for long-term investors. [14]
• Lux Capital has successfully executed multiple large-scale fund closes, including an $800 million growth-stage fund and a $675 million early-stage venture fund, demonstrating a diversified and robust fundraising track record across different stages. [12]

Cons

• The firm’s stated mission explicitly advocates for accelerating China’s brain drain and defending against foreign interference, which signals a geopolitical stance that may expose the manager to regulatory scrutiny or reputational risk in international markets. [2]
• Lux Capital’s strategy relies on a contrarian approach to backing non-consensus founders and sectors, which inherently carries higher execution risk and potential for underperformance compared to mainstream venture capital benchmarks. [9]
• The manager’s investment focus is concentrated in specific high-risk sectors such as AI-driven biotech, autonomous systems, and defense, creating sector concentration risk that could lead to significant losses if these specific technological trends fail to materialize. [9] [11]
• The firm’s long-term perspective, described as a “Five-Year Psychological Bias” emphasizing patience over a decade-long horizon, may result in capital being locked up for extended periods, reducing liquidity for LPs and increasing exposure to long-term market volatility. [9]
• Lux Capital’s strategy of supporting companies through downturns and facilitating strategic M&A indicates a willingness to hold underperforming assets for extended periods, which can lead to prolonged write-downs and delayed realization of losses for investors. [9]